Search

Your search keyword '"Cornely O"' showing total 985 results

Search Constraints

Start Over You searched for: Author "Cornely O" Remove constraint Author: "Cornely O"
985 results on '"Cornely O"'

Search Results

1. Kernaussagen und Empfehlungen der AWMF-Leitlinie „Medizinisch klinische Diagnostik bei Schimmelpilzexposition in Innenräumen“ – Update 2023

2. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

3. Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry

4. Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape

5. The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey

7. Onkologie

8. Infektiologie

12. Résultats par pathogènes en baseline et sensibilité dans l'essai de phase 3 ReSTORE de la rezafungine une fois par semaine vs caspofungine une fois par jour chez les patients atteints de candidémies et/ou de candidose invasive.

13. A second update on mapping the human genetic architecture of COVID-19

14. Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry

15. Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry

16. Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

17. Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope

18. Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

19. SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report

20. Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey

21. Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings

22. Effectiveness and Safety of Cefiderocol in Clinical Practice for Treatment of Patients with Gram-Negative Bacterial Infections: US Interim Results of the PROVE Study

23. P22 Patient-level meta-analysis of efficacy and safety from STRIVE and ReSTORE: randomized, double-blinded, multicentre Phase 2 and Phase 3 trials of rezafungin in the treatment of candidaemia and/or invasive candidiasis

25. Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

27. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

29. Infektiologie

30. Onkologie

32. S280: B-CELL MALIGNANCIES TREATED WITH TARGETED DRUGS AND SARS-COV-2 INFECTION. A EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA)

33. S281: PRIOR EXPOSURE TO IMMUNOSUPPRESSIVE AGENTS AND COMORBIDITIES ARE ASSOCIATED WITH WORSE OUTCOMES OF SARS-COV2 INFECTION IN PH-NEG CHRONIC MYELOPROLIFERATIVE NEOPLASMS: RESULTS OF EPICOVIDEHA SURVEY

35. P1576: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF V114 PNEUMOCOCCAL VACCINE IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS (PNEU-STEM)

38. Liposomal amphotericin B-the future

39. Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, non-neutropenic, adult patients: An update including COVID-19 data

40. B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)

41. COVID-19 and hairy-cell leukemia: An EPICOVIDEHA survey

42. Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey

43. Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report

44. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

45. ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures

Catalog

Books, media, physical & digital resources